Skip To Voice Support Menu
For Body
For Menu
For Local Menu
Site Map
Text Size
Normal
Home
About Chugai
Group Companies
Patients
Research and Development
Careers
Contact
Chugai Pharma USA, LLC is now Chugai Pharma USA, Inc
Aug 11, 2015 Caution Regarding False Solicitations on Behalf of Chugai
May 14, 2015 Warning against Phishing e-mails and social networking sites using the name of Chugai Pharmaceutical
News Releases
What's New
01 Jun
Chugai Selected as “DX Platinum Companies 2023-2025” in Digital Transformation Stocks (DX Stocks) 2023
30 May
Personnel Changes
30 May
New Investment of Over 50 Billion Yen in Bio Manufacturing Facilities to Strengthen the Production Base to Support the Rapid Launch of In-House Projects
26 May
Chugai Obtains Approval for FoundationOne Liquid CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for Novartis’ MET Inhibitor, Capmatinib, Which Is Approved for MET Exon 14 Skipping Mutation-Positive Advanced and/or Recurrent Unresectable Non-Small Cell Lung Cancer
More
Videos & Advertisements
Share this site